Mark P Rubinstein, PhD Ohio State cancer researcher

Mark P Rubinstein, PhD, is a Translational Therapeutics research program member at the OSUCCC – James. Learn more

Clinical characteristics, racial inequities, and outcomes in

Translational Therapeutics Research Program Members

Immunotherapy: Programming Your Immune System to Target Cancer

Mark P. Rubinstein's research works

Mark P. Rubinstein's research works

2020 Education & Research Fund Annual Report by AAPM Docs - Issuu

Oncology Data Advisor - Videos

Terri S. Armstrong, Ph.D., ANP-BC, FAAN, FAANP

Immunotherapeutic HCW9218 augments anti-tumor activity of

Mark P. Rubinstein's research works